OncoSec starts Phase II trial of Tavo and Keytruda for TNBC
OncoSec Medical has started the Phase II KEYNOTE-890 clinical trial of Tavo for the treatment...
OncoSec Medical has started the Phase II KEYNOTE-890 clinical trial of Tavo for the treatment...